. "Retraction: Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by Norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway." PLoS ONE (2025). https://doi.org/10.1371/journal.pone.0319593